GB2615103A - A method of forming a composition comprising a probiotic micro-encapsulated in a denatured plant protein matrix - Google Patents
A method of forming a composition comprising a probiotic micro-encapsulated in a denatured plant protein matrix Download PDFInfo
- Publication number
- GB2615103A GB2615103A GB2201083.9A GB202201083A GB2615103A GB 2615103 A GB2615103 A GB 2615103A GB 202201083 A GB202201083 A GB 202201083A GB 2615103 A GB2615103 A GB 2615103A
- Authority
- GB
- United Kingdom
- Prior art keywords
- protein
- suspension
- denatured
- probiotic
- plant protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000006041 probiotic Substances 0.000 title claims abstract description 81
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 79
- 238000000034 method Methods 0.000 title claims abstract description 71
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 67
- 108010064851 Plant Proteins Proteins 0.000 title claims abstract description 61
- 235000021118 plant-derived protein Nutrition 0.000 title claims abstract description 61
- 239000011159 matrix material Substances 0.000 title claims abstract description 26
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 239000000725 suspension Substances 0.000 claims abstract description 79
- 235000018102 proteins Nutrition 0.000 claims abstract description 69
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 69
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 69
- 238000001035 drying Methods 0.000 claims abstract description 28
- 239000000872 buffer Substances 0.000 claims abstract description 26
- 239000011859 microparticle Substances 0.000 claims abstract description 22
- 108010084695 Pea Proteins Proteins 0.000 claims abstract description 21
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 21
- 235000019702 pea protein Nutrition 0.000 claims abstract description 21
- 159000000007 calcium salts Chemical class 0.000 claims abstract description 15
- 239000013543 active substance Substances 0.000 claims abstract description 14
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims abstract description 13
- 239000001354 calcium citrate Substances 0.000 claims abstract description 13
- 235000013337 tricalcium citrate Nutrition 0.000 claims abstract description 13
- 239000012876 carrier material Substances 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 9
- 150000003839 salts Chemical class 0.000 claims abstract description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 6
- 239000008103 glucose Substances 0.000 claims abstract description 6
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 4
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 4
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 4
- 210000004777 protein coat Anatomy 0.000 claims abstract description 3
- 238000005507 spraying Methods 0.000 claims abstract description 3
- 238000010438 heat treatment Methods 0.000 claims description 31
- 239000007900 aqueous suspension Substances 0.000 claims description 20
- 241000894006 Bacteria Species 0.000 claims description 10
- 238000013019 agitation Methods 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- 238000004108 freeze drying Methods 0.000 claims description 7
- 239000003125 aqueous solvent Substances 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 238000001291 vacuum drying Methods 0.000 claims description 6
- 239000008363 phosphate buffer Substances 0.000 claims description 5
- 230000000284 resting effect Effects 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 4
- 230000002496 gastric effect Effects 0.000 claims description 4
- 230000000887 hydrating effect Effects 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 235000014633 carbohydrates Nutrition 0.000 description 15
- 238000005538 encapsulation Methods 0.000 description 15
- 230000004083 survival effect Effects 0.000 description 11
- 229960004256 calcium citrate Drugs 0.000 description 10
- 239000003094 microcapsule Substances 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 239000012460 protein solution Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 7
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 6
- 108010046377 Whey Proteins Proteins 0.000 description 6
- 102000007544 Whey Proteins Human genes 0.000 description 6
- 239000001110 calcium chloride Substances 0.000 description 6
- 229910001628 calcium chloride Inorganic materials 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 229960005069 calcium Drugs 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 235000021119 whey protein Nutrition 0.000 description 5
- 239000002738 chelating agent Substances 0.000 description 4
- 238000001125 extrusion Methods 0.000 description 4
- 230000036571 hydration Effects 0.000 description 4
- 238000006703 hydration reaction Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 229920001661 Chitosan Polymers 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 210000003405 ileum Anatomy 0.000 description 3
- 239000011325 microbead Substances 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 229940068977 polysorbate 20 Drugs 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000001879 gelation Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 240000006162 Chenopodium quinoa Species 0.000 description 1
- 244000045195 Cicer arietinum Species 0.000 description 1
- 235000010523 Cicer arietinum Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 1
- 244000043158 Lens esculenta Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 235000004240 Triticum spelta Nutrition 0.000 description 1
- 240000003834 Triticum spelta Species 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000011258 core-shell material Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 235000021309 simple sugar Nutrition 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/14—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/22—Working-up of proteins for foodstuffs by texturising
- A23J3/26—Working-up of proteins for foodstuffs by texturising using extrusion or expansion
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
- A23P20/10—Coating with edible coatings, e.g. with oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P30/00—Shaping or working of foodstuffs characterised by the process or apparatus
- A23P30/20—Extruding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/04—Making microcapsules or microballoons by physical processes, e.g. drying, spraying
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/04—Making microcapsules or microballoons by physical processes, e.g. drying, spraying
- B01J13/043—Drying and spraying
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/04—Making microcapsules or microballoons by physical processes, e.g. drying, spraying
- B01J13/046—Making microcapsules or microballoons by physical processes, e.g. drying, spraying combined with gelification or coagulation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/14—Polymerisation; cross-linking
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- General Preparation And Processing Of Foods (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicinal Preparation (AREA)
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2201083.9A GB2615103A (en) | 2022-01-27 | 2022-01-27 | A method of forming a composition comprising a probiotic micro-encapsulated in a denatured plant protein matrix |
| JP2024545159A JP2025503284A (ja) | 2022-01-27 | 2023-01-27 | 変性植物タンパク質マトリックス中にマイクロカプセル化されたプロバイオティクスを含む組成物を形成する方法 |
| KR1020247028480A KR20250008728A (ko) | 2022-01-27 | 2023-01-27 | 변성 식물 단백질 매트릭스에 마이크로-캡슐화된 프로바이오틱을 포함하는 조성물의 형성 방법 |
| CN202380025064.4A CN118891034A (zh) | 2022-01-27 | 2023-01-27 | 形成包含微胶囊化于变性植物蛋白质基质中的益生菌的组合物的方法 |
| KR1020267003440A KR20260030168A (ko) | 2022-01-27 | 2023-01-27 | 변성 식물 단백질 매트릭스에 마이크로-캡슐화된 프로바이오틱을 포함하는 조성물의 형성 방법 |
| EP23702555.6A EP4469026A1 (en) | 2022-01-27 | 2023-01-27 | A method of forming a composition comprising a probiotic micro-encapsulated in a denatured plant protein matrix |
| AU2023211849A AU2023211849A1 (en) | 2022-01-27 | 2023-01-27 | A method of forming a composition comprising a probiotic micro-encapsulated in a denatured plant protein matrix |
| PCT/EP2023/052095 WO2023144354A1 (en) | 2022-01-27 | 2023-01-27 | A method of forming a composition comprising a probiotic micro-encapsulated in a denatured plant protein matrix |
| US18/832,837 US20250090468A1 (en) | 2022-01-27 | 2023-01-27 | A method of forming a composition comprising a probiotic micro-encapsulated in a denatured plant protein matrix |
| CA3243396A CA3243396A1 (en) | 2022-01-27 | 2023-01-27 | METHOD FOR FORMING A COMPOSITION COMPRISING A PROBIOTIC MICRO-ENCAPSULATED IN A DENATURED VEGETABLE PROTEIN MATRIX |
| MX2024009160A MX2024009160A (es) | 2022-01-27 | 2024-07-24 | Un metodo para formar una composicion que comprende un probiotico microencapsulado en una matriz de proteina vegetal desnaturalizada |
| AU2026200643A AU2026200643A1 (en) | 2022-01-27 | 2026-01-29 | A method of forming a composition comprising a probiotic micro-encapsulated in a denatured plant protein matrix |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2201083.9A GB2615103A (en) | 2022-01-27 | 2022-01-27 | A method of forming a composition comprising a probiotic micro-encapsulated in a denatured plant protein matrix |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB202201083D0 GB202201083D0 (en) | 2022-03-16 |
| GB2615103A true GB2615103A (en) | 2023-08-02 |
Family
ID=80621316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2201083.9A Withdrawn GB2615103A (en) | 2022-01-27 | 2022-01-27 | A method of forming a composition comprising a probiotic micro-encapsulated in a denatured plant protein matrix |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250090468A1 (https=) |
| EP (1) | EP4469026A1 (https=) |
| JP (1) | JP2025503284A (https=) |
| KR (2) | KR20260030168A (https=) |
| CN (1) | CN118891034A (https=) |
| AU (2) | AU2023211849A1 (https=) |
| CA (1) | CA3243396A1 (https=) |
| GB (1) | GB2615103A (https=) |
| MX (1) | MX2024009160A (https=) |
| WO (1) | WO2023144354A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202011598D0 (en) * | 2020-07-27 | 2020-09-09 | Anabio Tech Limited | A pharmaceutical composition in oral dosage form |
| EP4599044A2 (en) * | 2022-10-03 | 2025-08-13 | VitaKey Inc. | Lipid encapsulated probiotic compositions |
| GB202304892D0 (en) | 2023-03-31 | 2023-05-17 | Anabio Tech Limited | A self-stable packed beverage |
| AU2024339695A1 (en) | 2023-09-11 | 2026-04-09 | New Cibo Vita Llc | A method of making a coated confectionary product |
| WO2025056631A1 (en) | 2023-09-11 | 2025-03-20 | Cibo Vita, Inc. | An edible product comprising a solid center and a coating of fatty material |
| GB202403584D0 (en) | 2024-03-12 | 2024-04-24 | Anabio Tech Limited | An enumeration method |
| WO2025202246A1 (en) * | 2024-03-25 | 2025-10-02 | Innovative Food Technologies LLC | Microencapsulates and uses thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015019307A1 (en) * | 2013-08-07 | 2015-02-12 | University Of Saskatchewan | Microcapsules containing probiotics and methods of making same |
| WO2019014222A1 (en) * | 2017-07-10 | 2019-01-17 | Mirablue Bio Llc | SYSTEMS OF ADMINISTRATION TO THE LOWER GASTROINTESTINAL TRACT |
| US20190099379A1 (en) * | 2017-09-29 | 2019-04-04 | Johnson & Johnson Consumer Inc. | Solid simethicone particles and dosage form thereof |
| CN111150068A (zh) * | 2018-11-06 | 2020-05-15 | 内蒙古蒙牛乳业(集团)股份有限公司 | 一种以复合材料为壁材的益生菌微胶囊及其制备方法 |
| CN112220775A (zh) * | 2020-11-01 | 2021-01-15 | 长沙晶易医药科技有限公司 | 一种含碳酸钙与维生素d3的制剂中间体颗粒及其制备方法 |
| US20210275461A1 (en) * | 2019-09-12 | 2021-09-09 | Nulixir Inc. | Particles for administration of active ingredients and methods of making the same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1958622A1 (en) | 2006-11-07 | 2008-08-20 | Royal College of Surgeons in Ireland | Method of producing microcapsules |
| US9788563B2 (en) * | 2011-04-15 | 2017-10-17 | Pepsico, Inc. | Encapsulation system for protection of probiotics during processing |
| CA2931835C (en) * | 2012-11-29 | 2021-02-23 | Progel Pty Ltd | Microparticles comprising a probiotic, cross-linkable reagent, a denatured protein, polyol plasticiser and trehalose |
| EP3042571A1 (en) * | 2014-12-15 | 2016-07-13 | Anabio Technologies Limited | A solution of denatured pea protein, and uses thereof to form microbeads |
| US11103550B2 (en) * | 2014-12-15 | 2021-08-31 | Anabio Technologies Limited | Gastro-resistant microencapsulates, and uses thereof to stimulate in-vivo ileal GLP-1 release in a mammal |
-
2022
- 2022-01-27 GB GB2201083.9A patent/GB2615103A/en not_active Withdrawn
-
2023
- 2023-01-27 KR KR1020267003440A patent/KR20260030168A/ko active Pending
- 2023-01-27 JP JP2024545159A patent/JP2025503284A/ja active Pending
- 2023-01-27 EP EP23702555.6A patent/EP4469026A1/en active Pending
- 2023-01-27 US US18/832,837 patent/US20250090468A1/en active Pending
- 2023-01-27 WO PCT/EP2023/052095 patent/WO2023144354A1/en not_active Ceased
- 2023-01-27 CN CN202380025064.4A patent/CN118891034A/zh active Pending
- 2023-01-27 CA CA3243396A patent/CA3243396A1/en active Pending
- 2023-01-27 AU AU2023211849A patent/AU2023211849A1/en active Pending
- 2023-01-27 KR KR1020247028480A patent/KR20250008728A/ko active Pending
-
2024
- 2024-07-24 MX MX2024009160A patent/MX2024009160A/es unknown
-
2026
- 2026-01-29 AU AU2026200643A patent/AU2026200643A1/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015019307A1 (en) * | 2013-08-07 | 2015-02-12 | University Of Saskatchewan | Microcapsules containing probiotics and methods of making same |
| WO2019014222A1 (en) * | 2017-07-10 | 2019-01-17 | Mirablue Bio Llc | SYSTEMS OF ADMINISTRATION TO THE LOWER GASTROINTESTINAL TRACT |
| US20190099379A1 (en) * | 2017-09-29 | 2019-04-04 | Johnson & Johnson Consumer Inc. | Solid simethicone particles and dosage form thereof |
| CN111150068A (zh) * | 2018-11-06 | 2020-05-15 | 内蒙古蒙牛乳业(集团)股份有限公司 | 一种以复合材料为壁材的益生菌微胶囊及其制备方法 |
| US20210275461A1 (en) * | 2019-09-12 | 2021-09-09 | Nulixir Inc. | Particles for administration of active ingredients and methods of making the same |
| CN112220775A (zh) * | 2020-11-01 | 2021-01-15 | 长沙晶易医药科技有限公司 | 一种含碳酸钙与维生素d3的制剂中间体颗粒及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3243396A1 (en) | 2023-08-03 |
| EP4469026A1 (en) | 2024-12-04 |
| AU2023211849A1 (en) | 2024-08-15 |
| MX2024009160A (es) | 2024-11-08 |
| JP2025503284A (ja) | 2025-01-30 |
| GB202201083D0 (en) | 2022-03-16 |
| AU2026200643A1 (en) | 2026-02-19 |
| US20250090468A1 (en) | 2025-03-20 |
| CN118891034A (zh) | 2024-11-01 |
| KR20260030168A (ko) | 2026-03-05 |
| WO2023144354A1 (en) | 2023-08-03 |
| KR20250008728A (ko) | 2025-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2615103A (en) | A method of forming a composition comprising a probiotic micro-encapsulated in a denatured plant protein matrix | |
| JP5950938B2 (ja) | マイクロカプセル化プロバイオティクス物質および製造方法 | |
| Bodmeier et al. | Spherical agglomerates of water‐insoluble drugs | |
| Islam et al. | Microencapsulation of live probiotic bacteria | |
| JP2012527898A5 (https=) | ||
| CN106723233B (zh) | 以蛋白聚集体-多糖为壁材的益生菌微胶囊及制备方法 | |
| CN102595938A (zh) | 耐热益生菌组合物及包含该组合物的健康食品 | |
| CN107970227A (zh) | 一种酪蛋白/海藻酸钠复合微囊的制备方法 | |
| CN104531664A (zh) | 一种以美拉德产物为壁材包埋乳酸菌的方法 | |
| CN116675785B (zh) | 巯基改性壳聚糖微球的制备方法及在益生菌包埋中的应用 | |
| CN112335884A (zh) | 一种新型益生菌微球及其制备方法 | |
| CN110313618A (zh) | 一种维生素d2微胶囊的制备方法 | |
| He et al. | Alginate-casein microspheres as bioactive vehicles for nutrients | |
| CN120514053A (zh) | 真菌毒素降解酶智能缓释饲料添加剂制备方法 | |
| CN115381101B (zh) | 一种基于复合凝聚法制备益生菌微胶囊的方法与应用 | |
| CN117158589B (zh) | 一种基于微流控芯片的核壳微胶囊的制备方法 | |
| EP3040373B1 (en) | Ionic gelation on solids | |
| JP2026071369A (ja) | 変性植物タンパク質マトリックス中にマイクロカプセル化されたプロバイオティクスを含む組成物を形成する方法 | |
| Petreska Ivanovska et al. | Comparative evaluation of viability of encapsulated Lactobacillus casei using two different methods of microencapsulation | |
| CN113230138B (zh) | 一种益生菌微胶囊连续化制备装置及其制备方法 | |
| CN1891301A (zh) | 一种纳米微凝胶、其制备方法及应用 | |
| CN120585732A (zh) | 一种帮助益生菌缓释增效的保护性水凝胶 | |
| CN121667388A (zh) | 一种基于乳铁蛋白水包油型益生菌乳液及其制备方法与应用 | |
| CN114831307A (zh) | 一种包埋生物活性物质的纳米颗粒的制备方法及其应用 | |
| CN121817479A (zh) | 一种调节肠胃的动物双歧杆菌乳亚种组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |